An offering was filed with and declared effective by the SEC on August 21, 2025, with Morgan Stanley and TD Cowen serving as joint book-running managers for Sana Biotechnology.

The entities involved

• Sana Biotechnology →

  biotechnology company

  Nothing else this week.

• Morgan Stanley →

  U.S. investment bank

  • Goldman Sachs and Morgan Stanley noted that semiconductor stocks benefit from current rate levels but face market caution.05:33
  • Morgan Stanley analysis coincided with Alphabet's stock drop following poor earnings and a suspected crypto hack triggering asset freezes.03:42
• TD Cowen →

  American investment bank

  • Wendy's is being analyzed for privatization prospects by TD Cowen amid Middle East war driving commodity price surges.Wed 22:01
  • Datadog saw institutional investment changes tracked by the SEC and received a buy rating from TD Cowen.Sun 09:24
• SEC →

  Slovak company

  • Cboe Global Markets received SEC approvals for new contracts and extended its exclusive S&P license through 2051.13:00
  • The SEC is actively engaged in Sri Lanka's capital markets, working with companies to prevent delisting.08:09

Related events

• An offering was filed with the SEC on July 22, 2025, involving Simmons Bank, with joint book-running management from Stephens Inc., Keefe, Bruyette & Woods, and Morgan Stanley, and co-management from Robert W. Baird & Co.Jun 8